Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
Romain Brette reveals fundamental flaws in commonly assumed neuroscience concepts
His new book, “The Brain, In Theory,” offers alternatives to many of the computer science frameworks currently driving theoretical neuroscience.
Romain Brette reveals fundamental flaws in commonly assumed neuroscience concepts
His new book, “The Brain, In Theory,” offers alternatives to many of the computer science frameworks currently driving theoretical neuroscience.
Arboreal deer mice reveal neural roots of dexterity
The rodents offered researchers an opportunity to link genetically driven changes in corticospinal abundance and morphology to climbing cachet.
Arboreal deer mice reveal neural roots of dexterity
The rodents offered researchers an opportunity to link genetically driven changes in corticospinal abundance and morphology to climbing cachet.
Single-gene systems-level effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 April.
Single-gene systems-level effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 6 April.